Breast cancer radiation after surgery with very short treatment doses
Part of Cancer, Skin clinical trials.
This study looks at giving radiation after breast surgery using a very “hypo-fractionated” schedule, meaning fewer visits with higher dose per visit. It aims to see if this approach is safe and effective for certain breast cancer and DCIS patients after complete tumor removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed invasive breast cancer or DCIS (a non-invasive early form).
- Your surgery removed all visible tumor (R0) and there is no spread to distant organs (M0).
- You cannot have cancer in the other breast/side (no contralateral breast cancer or DCIS).
- You are at least 18 years old and able to do daily activities at a moderate level (Karnofsky score 60 or higher).
- You must be willing and able to follow the study’s treatment and follow-up visits, and sign consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
This trial tests shorter radiation schedules for people with breast cancer that has spread to lymph nodes or is high-risk. It aims to find a shorter course of radiation that is just as effective after surgery.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
This trial tests giving a single, very targeted dose of radiation right after surgery for early-stage breast cancer. It is for women age 40+ with small, low-risk tumors (Luminal A or B) that have been fully removed and have not spread to lymph nodes.
This study compares a shorter course of radiation to a standard longer course after breast-conserving surgery (lumpectomy). It’s meant to see which schedule works just as well while focusing on safety and cancer control.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.